Atlas Trials

GlobeImmune

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch GlobeImmune

RecordFirmDate
A Pilot Phase 2 Trial of the Immunogenicity, and Safety of GI-4000; an Inactivated Recombinant S. Cerevisiae Expressing Mutant Ras Protein, as Consolidation Therapy Following Curative Treatment for Stage I-III Non-Small Cell Lung Cancer (NSCLC) With Tumor Sequence Confirmation of K-ras Mutation (NCT00655161)GlobeImmune2008-04-01
Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C Infection (NCT00606086)GlobeImmune2007-12-01
Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas Cancer (NCT00300950)GlobeImmune2006-01-01
Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C Infection (NCT00124215)GlobeImmune2005-06-01

Track GlobeImmune automatically

Every clearance here is in the API, with alerts when new ones post.